Pharmacokinetics of orally administered zidovudine among patients with hemophilia and a symptomatic human immunodeficiency virus (HIV) infection
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 11 (2) , 57-65
- https://doi.org/10.1016/0166-3542(89)90008-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- Stability and inactivation of HTLV-III/LAV under clinical and laboratory environmentsJAMA, 1986
- Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.Journal of Clinical Investigation, 1985
- LAGRAN program for area and moments in pharmacokinetic analysisComputer Programs in Biomedicine, 1983
- Altered elimination of antipyrine in patients with acute viral hepatitis.Gut, 1976
- Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recoveryClinical Pharmacology & Therapeutics, 1975
- Asymptomatic liver disease in haemophiliacs.Journal of Clinical Pathology, 1975